623585-97-7

Usage

Uses

Used in Pharmaceutical Industry:
Benzyl (3S,5R)-3,5-dimethylpiperazine-1-carboxylate is used as an intermediate or building block in the synthesis of various pharmaceutical ingredients. Its unique structure and functional groups make it a valuable component in the development of new drugs and medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, benzyl (3S,5R)-3,5-dimethylpiperazine-1-carboxylate is employed as a precursor in the production of agrochemicals. Its properties allow it to be incorporated into formulations that can enhance crop protection and improve agricultural yields.
Used in Fine Chemicals Industry:
Benzyl (3S,5R)-3,5-dimethylpiperazine-1-carboxylate is also utilized in the synthesis of fine chemicals, which are high-purity chemicals used in various applications such as research, specialty manufacturing, and high-value consumer products. Its versatility and reactivity contribute to the creation of a wide range of specialty chemicals.

Upstream product

• 501-53-1 benzyl chloroformate 
• 21655-48-1 cis-2,6-dimethylpiperazine 

Downstream Products

• 1194373-99-3 (3R,5S)-benzyl 4-(2-(tert-butyldimethylsilyloxy)ethyl)-3,5-dimethylpiperazine-1-carboxylate 
• 2080367-38-8 4-benzyl 1-(tert-butyl) (2R,6S)-2,6-dimethylpiperazine-1,4-dicarboxylate 
• 574007-62-8 (2R,6S)-2,6-dimethyl-piperazine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) in-hibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and be-havioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, de? formations and chromosomal abnormalities.

CHEMICAL COMPOUNDS

The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof which possess CSF-IR kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.